Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 702 | $427,152,584 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 196 | 968.2 | 189,767 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 17 | 966.3 | 16,427 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 78 | 965.51 | 75,310 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 1 | 962.87 | 963 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 512 | 959.36 | 491,192 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 47 | 961.74 | 45,202 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 730 | 957.35 | 698,866 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 477 | 958.34 | 457,128 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 1,108 | 956.34 | 1,059,625 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 545 | 955.54 | 520,769 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 870 | 954.66 | 830,554 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 576 | 953.77 | 549,372 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 444 | 952.4 | 422,866 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 182 | 951.92 | 173,249 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Mar 2024 | Sale | 358 | 967.5 | 346,365 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 1 | 988.3 | 988 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 4 | 987.33 | 3,949 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 8 | 986.58 | 7,893 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 10 | 985.76 | 9,858 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 12 | 983.61 | 11,803 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 19 | 984.45 | 18,705 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 11 | 982.67 | 10,809 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 15 | 981.64 | 14,725 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 1 | 980.21 | 980 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 1 | 979.87 | 980 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 1 | 978.09 | 978 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 2 | 976.81 | 1,954 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 2 | 977.27 | 1,955 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 2 | 975.7 | 1,951 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 1 | 974.78 | 975 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 2 | 972.29 | 1,945 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 1 | 971.75 | 972 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 4 | 970.38 | 3,882 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 1 | 969.18 | 969 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 1 | 968.66 | 969 | D |
05 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2024 | Sale | 1 | 967.5 | 968 | D |
28 Feb 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | SING GEORGE L | Director | 26 Feb 2024 | Sale | 500 | 990 | 495,000 | D |
28 Feb 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | SING GEORGE L | Director | 26 Feb 2024 | Sale | 500 | 995 | 497,500 | D |
28 Feb 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | LAROSA JOSEPH J | EVP General Counsel and Secret | 26 Feb 2024 | Sale | 1,000 | 990 | 990,000 | D |
26 Feb 2024 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | SING GEORGE L | Director | 23 Feb 2024 | Sale | 500 | 985 | 492,500 | D |
26 Feb 2024 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | SING GEORGE L | Director | 22 Feb 2024 | Sale | 1,000 | 960 | 960,000 | D |
26 Feb 2024 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | SING GEORGE L | Director | 22 Feb 2024 | Sale | 1,000 | 965 | 965,000 | D |
26 Feb 2024 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | SING GEORGE L | Director | 22 Feb 2024 | Sale | 1,000 | 970 | 970,000 | D |
26 Feb 2024 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LAROSA JOSEPH J | EVP General Counsel and Secret | 22 Feb 2024 | Sale | 1,000 | 967.65 | 967,650 | D |
26 Feb 2024 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 26 Feb 2024 | Sale | 854 | 979.25 | 836,280 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 200 | 951.77 | 190,354 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 375 | 950.45 | 356,419 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 112 | 949.07 | 106,296 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 150 | 948.7 | 142,305 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 240 | 947.81 | 227,474 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 95 | 945.81 | 89,852 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 620 | 944.3 | 585,466 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 2,691 | 943.51 | 2,538,985 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 275 | 941.41 | 258,888 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 750 | 939.6 | 704,700 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 4,261 | 940.44 | 4,007,215 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 226 | 938.13 | 212,017 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 439 | 937.94 | 411,756 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 09 Feb 2024 | Sale | 600 | 955 | 573,000 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 09 Feb 2024 | Sale | 1,100 | 954.57 | 1,050,027 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 09 Feb 2024 | Sale | 1,342 | 953.47 | 1,279,557 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 09 Feb 2024 | Sale | 1,046 | 952.62 | 996,441 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 09 Feb 2024 | Sale | 487 | 951.39 | 463,327 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Finance & CFO | 09 Feb 2024 | Sale | 344 | 950.49 | 326,969 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | SING GEORGE L | Director | 09 Feb 2024 | Sale | 500 | 955 | 477,500 | D |
12 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | SING GEORGE L | Director | 08 Feb 2024 | Sale | 500 | 945 | 472,500 | D |
09 Feb 2024 16:12 | REGN | REGENERON PHARMACEUTICALS Inc | LAROSA JOSEPH J | EVP General Counsel and Secret | 07 Feb 2024 | Sale | 1,000 | 950 | 950,000 | D |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 19 | 953 | 18,107 | D |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 1,059 | 952.49 | 1,008,687 | D |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 1,237 | 951.49 | 1,176,993 | D |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 3,127 | 950.43 | 2,971,995 | D |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 601 | 949.45 | 570,619 | D |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 1,894 | 948.69 | 1,796,819 | D |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 100 | 947.34 | 94,734 | D |
06 Feb 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 05 Feb 2024 | Sale | 1,000 | 934.71 | 934,710 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 4 | 963.73 | 3,855 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 6 | 962.49 | 5,775 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 4 | 961.37 | 3,845 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 10 | 960.52 | 9,605 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 8 | 959.68 | 7,677 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 5 | 958.65 | 4,793 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 3 | 957.75 | 2,873 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 7 | 956.21 | 6,693 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 10 | 955.35 | 9,554 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 3 | 953.18 | 2,860 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 5 | 954.52 | 4,773 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 3 | 951.4 | 2,854 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 2 | 950.01 | 1,900 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 10 | 949.48 | 9,495 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 3 | 947.37 | 2,842 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 1 | 948.77 | 949 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 1 | 944.66 | 945 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 3 | 943.54 | 2,831 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 5 | 942.5 | 4,712 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 6 | 941.91 | 5,651 | D |
05 Feb 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2024 | Sale | 1 | 939.53 | 940 | D |
02 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Feb 2024 | Sale | 273 | 945.61 | 258,152 | D |
31 Jan 2024 16:52 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 30 Jan 2024 | Sale | 827 | 959 | 793,093 | D |
25 Jan 2024 16:18 | REGN | REGENERON PHARMACEUTICALS Inc | GOLDSTEIN JOSEPH L | Director | 23 Jan 2024 | Sale | 2,707 | 950 | 2,571,650 | D |
04 Jan 2024 16:20 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 02 Jan 2024 | Sale | 16,848 | 900 | 15,163,200 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)